Elderly residents given intensive therapy in the last weeks of life jumped 65 percent, a study shows, raising questions about financial incentives

Quick Read

And drug makers would still make healthy profits. As prices for diabetes treatments continue to roil consumers, a new study suggests that manufacturers could make both human and analog insulins at low costs and still pocket a profit.

Quick Read

In the United States, pharmaceutical companies have built a system which supports high costs for HIV drugs. But that may be starting to change

Quick Read

Settlement ensures care of 2,200 state prisoners with hepatitis C. Inmates will no longer be required to undergo drug or alcohol treatment as a precondition for care

Quick Read

The CRISPR patent dispute between the University of California, Berkeley, and the Broad Institute is finally over

Quick Read

Procedures live on even after they’ve been proved ineffective. It can lead to harms and wasted resources

Quick Read

A desperate but determined group of parents raised millions through golf tournaments and cocktail parties to support research for drugs to fight cystinosis, a rare, fatal childhood disease. They were ecstatic when a pill called Procysbi was approved in 2013

Quick Read

So they’re starting their own. A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages of critical medicines, has launched a mission-driven, not-for-profit generic drug company, Civica Rx, to take some control over the drug supply

Quick Read